LOS ANGELES, California, Aug. 27 [Category: BizLaw/Legal] -- Paul Hastings, a law firm, issued the following news:

* * *

Paul Hastings Advises SK Biopharmaceuticals on Opakalim Licensing From Biohaven

*

Paul Hastings LLP advised SK Biopharmaceuticals Co. Ltd. on its agreement to in-license opakalim, an investigational antiseizure medication, from Biohaven Ltd. and/or its wholly owned subsidiaries. The agreement provides for upfront and mileston . . .

Click here for more information about our products